Geoffrey Martha - 26 May 2026 Form 4 Insider Report for Medtronic plc (MDT)

Reporting relationship: Chairman and CEO, Director
Issuer ticker: MDT
Reported as of: 26 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 28 May 2026, 16:25:58 UTC
Prior SEC filing: 13 Feb 2026
Next SEC filing: 08 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Patricia Walesiewicz, attorney-in-fact

Key filing fact

Geoffrey Martha filed Form 4 for Medtronic plc (MDT) on 28 May 2026.

Key facts

This page summarizes Geoffrey Martha's Form 4 filing for Medtronic plc (MDT).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 28 May 2026, 16:25.

Change

Previous filing in this sequence was filed on 13 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001560409 Primary reporting owner

Martha Geoffrey

Relationship: Chairman and CEO, Director
Address: 710 MEDTRONIC PARKWAY, MINNEAPOLIS
Signature: /s/ Patricia Walesiewicz, attorney-in-fact
Signature date: 28 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MDT transaction

Ordinary Shares

Options Exercise

Transaction value
Shares: +94,963
Change %: +38%
Price: $0.000000^*
Shares after: 343,099
Date: 26 May 2026
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MDT transaction Derivative

Performance Share Unit

Options Exercise

Transaction value
Shares: -85,461
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 26 May 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 85,461
Exercise price
Footnotes: F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents shares issued upon the settlement of performance-vesting share units granted on July 31, 2023, based on performance as certified on May 26, 2026.

Footnote F2

Includes 1,743 shares acquired through dividend reinvestment since the last report filed by the reporting person.

Footnote F3

Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

Footnote F4

The performance share units vested on April 24, 2026.